Asia Pacific Clinical Trial Imaging Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]

No. of Pages: 134    |    Report Code: BMIRE00028597    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Clinical Trial Imaging Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Clinical Trial Imaging Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Clinical Trial Imaging Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biopharmaceutical Industries
  • 5.1.2 Spur in Number of CROS Offering Medical Imaging Services
5.2 Market Opportunities
  • 5.2.1 In-Silico Imaging Clinical Trials
5.3 Future Trends
  • 5.3.1 Al-Driven Clinical Trials
5.4 Impact of Drivers and Restraints

6. Asia Pacific Clinical Trial Imaging Market Regional Analysis

6.1 Asia Pacific Clinical Trial Imaging Market Overview
6.2 Asia Pacific Clinical Trial Imaging Market Revenue 2021-2028 (US$ Million)
6.3 Asia Pacific Clinical Trial Imaging Market Forecast Analysis

7. Asia Pacific Clinical Trial Imaging Market Analysis – by Modality

7.1 Tomography
  • 7.1.1 Overview
  • 7.1.2 Tomography: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Magnetic Resonance Imaging
  • 7.2.1 Overview
  • 7.2.2 Magnetic Resonance Imaging: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Ultrasound
  • 7.3.1 Overview
  • 7.3.2 Ultrasound: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Positron Emission Tomography
  • 7.4.1 Overview
  • 7.4.2 Positron Emission Tomography: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.5 X-Ray
  • 7.5.1 Overview
  • 7.5.2 X-Ray: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Echocardiography
  • 7.6.1 Overview
  • 7.6.2 Echocardiography: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Clinical Trial Imaging Market Analysis – by Offering

8.1 Operational Imaging Services
  • 8.1.1 Overview
  • 8.1.2 Operational Imaging Services: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Imaging Software
  • 8.2.1 Overview
  • 8.2.2 Imaging Software: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Read Analysis Services
  • 8.3.1 Overview
  • 8.3.2 Read Analysis Services: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Trial Design and Consulting Services
  • 8.4.1 Overview
  • 8.4.2 Trial Design and Consulting Services: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Clinical Trial Imaging Market Analysis – by End User

9.1 Contract Research Organizations
  • 9.1.1 Overview
  • 9.1.2 Trial Design and Consulting Services: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Pharmaceutical and Biotechnology Companies
  • 9.2.1 Overview
  • 9.2.2 Trial Design and Consulting Services: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Academic and Research Institutes
  • 9.3.1 Overview
  • 9.3.2 Trial Design and Consulting Services: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Others
  • 9.4.1 Overview
  • 9.4.2 Trial Design and Consulting Services: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Clinical Trial Imaging Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Clinical Trial Imaging Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 10.1.1.1 Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Clinical Trial Imaging Market Breakdown, by Modality
    • 10.1.1.1.2 China: Asia Pacific Clinical Trial Imaging Market Breakdown, by Offering
    • 10.1.1.1.3 China: Asia Pacific Clinical Trial Imaging Market Breakdown, by End User
  • 10.1.1.2 India: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Clinical Trial Imaging Market Breakdown, by Modality
    • 10.1.1.2.2 India: Asia Pacific Clinical Trial Imaging Market Breakdown, by Offering
    • 10.1.1.2.3 India: Asia Pacific Clinical Trial Imaging Market Breakdown, by End User
  • 10.1.1.3 Japan: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Clinical Trial Imaging Market Breakdown, by Modality
    • 10.1.1.3.2 Japan: Asia Pacific Clinical Trial Imaging Market Breakdown, by Offering
    • 10.1.1.3.3 Japan: Asia Pacific Clinical Trial Imaging Market Breakdown, by End User
  • 10.1.1.4 Australia: Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Clinical Trial Imaging Market Breakdown, by Modality
    • 10.1.1.4.2 Australia: Asia Pacific Clinical Trial Imaging Market Breakdown, by Offering
    • 10.1.1.4.3 Australia: Asia Pacific Clinical Trial Imaging Market Breakdown, by End User
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Clinical Trial Imaging Market Breakdown, by Modality
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Clinical Trial Imaging Market Breakdown, by Offering
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Clinical Trial Imaging Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Clinical Trial Imaging Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Calyx Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 eResearch Technology Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 ICON PLC
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 IXICO plc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Medical Metrics Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Radiant Sage LLC
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 VIDA Diagnostics Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 WCG Clinical Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Calyx Inc
  2. eResearch Technology Inc
  3. ICON PLC
  4. IXICO plc
  5. Medical Metrics Inc
  6. Radiant Sage LLC
  7. VIDA Diagnostics Inc
  8. WCG Clinical Inc
asia-pacific-clinical-trial-imaging-market